VOLUME 6 (2015)
View Archive »
About The Cover
See Tseng et al. Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo; Role in osteoclast-mediated NK cell activation
|
|
Table of Contents
Editorial
|
| Targeting splenic hematopoietic stem cells in cardiovascular disease |
|
https://doi.org/10.18632/oncotarget.4918
|
| 19918-19919 |
|
| The host cell side of latent HIV1 infection |
|
https://doi.org/10.18632/oncotarget.5101
|
| 19920-19921 |
|
| Platelet signaling blood’s great balancing act |
|
https://doi.org/10.18632/oncotarget.5122
|
| 19922-19923 |
|
| Gammacarboxylation regulates osteocalcin function |
|
https://doi.org/10.18632/oncotarget.5126
|
| 19924-19925 |
|
| Arcuate nucleus glucokinase and dietary glucose intake |
|
https://doi.org/10.18632/oncotarget.5138
|
| 19926-19927 |
Editorial: Immunology
|
| A new “sweet†ligand for Tolllike receptor 4 |
|
https://doi.org/10.18632/oncotarget.4562
|
| 19928-19929 |
|
| Deciphering the biology of NKG2C+ Natural Killer cells |
|
https://doi.org/10.18632/oncotarget.4468
|
| 19930-19931 |
|
| NK cells in asthma exacerbation |
|
https://doi.org/10.18632/oncotarget.4841
|
| 19932-19933 |
|
| Immunodeficiency and CARDBCL10MALT1 |
|
https://doi.org/10.18632/oncotarget.4467
|
| 19934-19935 |
|
| The ‘inflammatory’ control of hematopoietic stem cells |
|
https://doi.org/10.18632/oncotarget.4591
|
| 19938-19939 |
|
| Notch metabolism and macrophages |
|
https://doi.org/10.18632/oncotarget.4651
|
| 19942-19943 |
|
| Basal body docking in airway ciliated cells |
|
https://doi.org/10.18632/oncotarget.4609
|
| 19944-19945 |
|
| CX3CR1 in multiple sclerosis |
|
https://doi.org/10.18632/oncotarget.4650
|
| 19946-19947 |
|
| BTK: sensing pathogenic nucleic acids |
|
https://doi.org/10.18632/oncotarget.4778
|
| 19948-19949 |
|
| NLRP12 in autoimmune diseases |
|
https://doi.org/10.18632/oncotarget.4585
|
| 19950-19951 |
|
| Sox5 and Th17 cell differentiation |
|
https://doi.org/10.18632/oncotarget.4784
|
| 19952-19953 |
|
| Sec61 in antigen crosspresentation |
|
https://doi.org/10.18632/oncotarget.4587
|
| 19954-19955 |
|
| Treg: tolerance vs immunity |
|
https://doi.org/10.18632/oncotarget.4648
|
| 19956-19957 |
|
| Effector Tregs: middlemen in TGFβ activation |
|
https://doi.org/10.18632/oncotarget.4686
|
| 19958-19959 |
|
| IFN type III: in vivo NK cell response |
|
https://doi.org/10.18632/oncotarget.4758
|
| 19960-19961 |
|
| Microbial control of intestinal innate immunity |
|
https://doi.org/10.18632/oncotarget.4780
|
| 19962-19963 |
|
| iCD8α cells: living at the edge of the intestinal immune system |
|
https://doi.org/10.18632/oncotarget.4782
|
| 19964-19965 |
|
| Selfcontrol for IgE production |
|
https://doi.org/10.18632/oncotarget.4806
|
| 19966-19967 |
Reviews
|
| Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wildtype tumors |
|
https://doi.org/10.18632/oncotarget.4847
|
| 19968-19975 |
|
| Going viral: a review of replicationselective oncolytic adenoviruses |
|
https://doi.org/10.18632/oncotarget.5116
|
| 19976-19989 |
Priority Research Papers
|
| Loss of p53 enhances the function of the endoplasmic reticulum through activation of the IRE1α/XBP1 pathway |
|
https://doi.org/10.18632/oncotarget.4598
|
| 19990-20001 |
Research Papers: Immunology
|
| Bisphosphonateinduced differential modulation of immune cell function in gingiva and bone marrow in vivo: Role in osteoclastmediated NK cell activation |
|
https://doi.org/10.18632/oncotarget.4755
|
| 20002-20025 |
|
| Helios and not FoxP3 is the marker of activated Tregs expressing GARP/LAP |
|
https://doi.org/10.18632/oncotarget.4771
|
| 20026-20036 |
|
| A novel human STAT3 mutation presents with autoimmunity involving Th17 hyperactivation |
|
https://doi.org/10.18632/oncotarget.5042
|
| 20037-20042 |
|
| Survivin coordinates formation of follicular Tcells acting in synergy with Bcl6 |
|
https://doi.org/10.18632/oncotarget.4994
|
| 20043-20057 |
Research Papers
|
| CD80CD28 signaling controls the progression of inflammatory colorectal carcinogenesis |
|
https://doi.org/10.18632/oncotarget.2780
|
| 20058-20069 |
|
| MicroRNA101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL1 expression in human triplenegative breast cancer |
|
https://doi.org/10.18632/oncotarget.4039
|
| 20070-20083 |
|
| A smallmolecule inhibitor suppresses the tumorassociated mitochondrial NADP+dependent malic enzyme ME2 and induces cellular senescence |
|
https://doi.org/10.18632/oncotarget.3907
|
| 20084-20098 |
|
| Clinical next generation sequencing to identify actionable aberrations in a phase I program |
|
https://doi.org/10.18632/oncotarget.4040
|
| 20099-20110 |
|
| Tanshinones suppress AURKA through upregulation of miR32 expression in nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.3933
|
| 20111-20120 |
|
| A novel SAHAbendamustine hybrid induces apoptosis of leukemia cells |
|
https://doi.org/10.18632/oncotarget.4041
|
| 20121-20131 |
|
| Combined targeting of EGFR/HER promotes antitumor efficacy in subsets of KRAS mutant lung cancer resistant to single EGFR blockade |
|
https://doi.org/10.18632/oncotarget.3853
|
| 20132-20144 |
|
| In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma |
|
https://doi.org/10.18632/oncotarget.3980
|
| 20145-20159 |
|
| Genomic characterization of a large panel of patientderived hepatocellular carcinoma xenograft tumor models for preclinical development |
|
https://doi.org/10.18632/oncotarget.3969
|
| 20160-20176 |
|
| The 1433σ/GSK3β/βcatenin/ZEB1 regulatory loop modulates chemosensitivity in human tongue cancer |
|
https://doi.org/10.18632/oncotarget.3896
|
| 20177-20189 |
|
| Overexpression of MAPK15 in gastric cancer is associated with copy number gain and contributes to the stability of cJun |
|
https://doi.org/10.18632/oncotarget.4171
|
| 20190-20203 |
|
| High CD204+ tumorinfiltrating macrophage density predicts a poor prognosis in patients with urothelial cell carcinoma of the bladder |
|
https://doi.org/10.18632/oncotarget.3887
|
| 20204-20214 |
|
| FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitro |
|
https://doi.org/10.18632/oncotarget.4046
|
| 20215-20230 |
|
| Efficacy of the pololike kinase inhibitor rigosertib alone or in combination with abelson tyrosine kinase inhibitors against break point cluster regioncAbelsonpositive leukemia cells |
|
https://doi.org/10.18632/oncotarget.4047
|
| 20231-20240 |
|
| Enhanced antitumor efficacy of ultrasonic cavitation with upsized microbubbles in pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.4048
|
| 20241-20251 |
|
| BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis |
|
https://doi.org/10.18632/oncotarget.3857
|
| 20252-20265 |
|
| Mechanism for enhanced 5aminolevulinic acid fluorescence in isocitrate dehydrogenase 1 mutant malignant gliomas |
|
https://doi.org/10.18632/oncotarget.4060
|
| 20266-20277 |
|
| Detecting cellincell structures in human tumor samples by Ecadherin/CD68/CD45 triple staining |
|
https://doi.org/10.18632/oncotarget.4275
|
| 20278-20287 |
|
| Hypoxia attenuates the proinflammatory response in colon cancer cells by regulating IκB |
|
https://doi.org/10.18632/oncotarget.3961
|
| 20288-20301 |
|
| The IgH 3’ regulatory region influences lymphomagenesis in IgλMyc mice |
|
https://doi.org/10.18632/oncotarget.3963
|
| 20302-20311 |
|
| Snail and serpinA1 promote tumor progression and predict prognosis in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.3964
|
| 20312-20326 |
|
| Inflammatory and oncogenic roles of a tumor stem cell marker doublecortinlike kinase DCLK1 in virusinduced chronic liver diseases |
|
https://doi.org/10.18632/oncotarget.3972
|
| 20327-20344 |
|
| A novel oHSV1 targeting telomerase reverse transcriptasepositive cancer cells via tumorspecific promoters regulating the expression of ICP4 |
|
https://doi.org/10.18632/oncotarget.3884
|
| 20345-20355 |
|
| PC1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4EBP1 stability |
|
https://doi.org/10.18632/oncotarget.3931
|
| 20356-20369 |
|
| Simultaneous inhibition of multiple oncogenic miRNAs by a multipotent microRNA sponge |
|
https://doi.org/10.18632/oncotarget.4827
|
| 20370-20387 |
|
| ROS1 amplification mediates resistance to gefitinib in glioblastoma cells |
|
https://doi.org/10.18632/oncotarget.3981
|
| 20388-20395 |
|
| Mutated Fanconi anemia pathway in nonFanconi anemia cancers |
|
https://doi.org/10.18632/oncotarget.4056
|
| 20396-20403 |
|
| Upregulated long noncoding RNA AFAP1AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.4057
|
| 20404-20418 |
|
| The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma |
|
https://doi.org/10.18632/oncotarget.3983
|
| 20419-20433 |
|
| Overexpression of microRNA953p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1 |
|
https://doi.org/10.18632/oncotarget.3886
|
| 20434-20448 |
|
| Epigenetically downregulated Semaphorin 3E contributes to gastric cancer |
|
https://doi.org/10.18632/oncotarget.3936
|
| 20449-20465 |
|
| Highly sensitive and quantitative evaluation of the EGFR T790M mutation by nanofluidic digital PCR |
|
https://doi.org/10.18632/oncotarget.4058
|
| 20466-20473 |
|
| Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression |
|
https://doi.org/10.18632/oncotarget.4105
|
| 20474-20484 |
|
| CCL18mediated downregulation of miR98 and miR27b promotes breast cancer metastasis |
|
https://doi.org/10.18632/oncotarget.4107
|
| 20485-20499 |
|
| Tumorigenesis and peritoneal colonization from fallopian tube epithelium |
|
https://doi.org/10.18632/oncotarget.3985
|
| 20500-20512 |
|
| An increase in glucosylceramide synthase induces BclxLmediated cell survival in vinorelbineresistant lung adenocarcinoma cells |
|
https://doi.org/10.18632/oncotarget.4109
|
| 20513-20524 |
|
| Type II transglutaminase stimulates epidermal cancer stem cell epithelialmesenchymal transition |
|
https://doi.org/10.18632/oncotarget.3890
|
| 20525-20539 |
|
| Dragon repulsive guidance molecule b RGMb is a novel gene that promotes colorectal cancer growth |
|
https://doi.org/10.18632/oncotarget.4110
|
| 20540-20554 |
|
| Jak3 STAT3 and STAT5 inhibit expression of miR22 a novel tumor suppressor microRNA in cutaneous TCell lymphoma |
|
https://doi.org/10.18632/oncotarget.4111
|
| 20555-20569 |
|
| Inhibition of RSK with the novel smallmolecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells |
|
https://doi.org/10.18632/oncotarget.4135
|
| 20570-20577 |
|
| Acetylation at lysine 71 inactivates superoxide dismutase 1 and sensitizes cancer cells to genotoxic agents |
|
https://doi.org/10.18632/oncotarget.3987
|
| 20578-20591 |
|
| Circulating and tumorinfiltrating Tim3 in patients with colorectal cancer |
|
https://doi.org/10.18632/oncotarget.4112
|
| 20592-20603 |
|
| The LPA1/ZEB1/miR21activation pathway regulates metastasis in basal breast cancer |
|
https://doi.org/10.18632/oncotarget.3774
|
| 20604-20620 |
|
| Increased resistance to proteasome inhibitors in multiple myeloma mediated by cIAP2 implications for a combinatorial treatment |
|
https://doi.org/10.18632/oncotarget.4139
|
| 20621-20635 |
|
| Insulinlike growth factor binding protein 5 IGFBP5 functions as a tumor suppressor in human melanoma cells |
|
https://doi.org/10.18632/oncotarget.4114
|
| 20636-20649 |
|
| Mutation of Nlinked glycosylation at Asn548 in CD133 decreases its ability to promote hepatoma cell growth |
|
https://doi.org/10.18632/oncotarget.4115
|
| 20650-20660 |
|
| RNA sequencing reveals differentially expressed genes as potential diagnostic and prognostic indicators of gallbladder carcinoma |
|
https://doi.org/10.18632/oncotarget.3861
|
| 20661-20671 |
|
| Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma |
|
https://doi.org/10.18632/oncotarget.3967
|
| 20672-20684 |
|
| CUEDC2 downregulation is associated with tumor growth and poor prognosis in lung adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.3930
|
| 20685-20696 |
|
| AF1q is a novel TCF7 cofactor which activates CD44 and promotes breast cancer metastasis |
|
https://doi.org/10.18632/oncotarget.4136
|
| 20697-20710 |
|
| SOX9 a potential tumor suppressor in cervical cancer transactivates p21WAF1/CIP1 and suppresses cervical tumor growth |
|
https://doi.org/10.18632/oncotarget.4133
|
| 20711-20722 |
|
| Hypoxia promotes colon cancer dissemination through upregulation of cell migrationinducing protein CEMIP |
|
https://doi.org/10.18632/oncotarget.3978
|
| 20723-20739 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
